Mold & Mycotoxin: The Hidden Enemy of Flow and Peak Performance

In this episode:

Intro (0:00)
Health Challenges & Recovery (05:22)
Issues That Decrease Cognitive Function (12:30)
Mold & Peak Performance (16:29)
Environmental Toxic Load (24:13)
Lyme Disease & Heavy Metals (26:40)
Gut Health (29:38)
Limbic Retraining (33:49)
Most Helpful Metric for Health (38:53)
The Future of Performance Medicine (42:49)
Research Genie Question (45:17)

TODAY´S EPISODE IS BROUGHT TO YOU BY THE FLOW RESEARCH COLLECTIVE

Are you an entrepreneur, a leader, or a knowledge worker, who wants to harness the power of flow so you can get more done in less time with greater ease and accomplish your boldest professional goals faster? If you’ve answered this question with “hell yes” then our peak-performance training Zero to Dangerous may be a good fit for you. If this sounds of interest to you all you need to do is click here right now, pop in your application and one of our team members will be in touch with you very soon.

ABOUT THE GUEST:

Dr. Jill is Your Functional Medicine Expert! She uses functional medicine help find personalized answers to the root cause of disease by examining the nutritional and biochemical imbalances, instead of just treating the symptoms.

Dr. Jill searches for underlying triggers that contribute to illnesses through cutting edge lab testing and then tailors the intervention to an individuals specific needs. She uses diet, supplements, lifestyle changes or medication to treat illnesses but will seek the most gentle way to help restore balance along with the least invasive treatment possible. She seeks to promote wellness and create hope, health and healing!

RESOURCES

STEVEN KOTLER is a New York Times bestselling author, award-winning journalist, and Founder and Executive Director of the Flow Research Collective. He is one of the world’s leading experts on human performance.

His books include The Art of Impossible, Stealing Fire, and The Rise of Superman. His work has been translated into over 40 languages and appeared in over 100 publications, including the New York Times Magazine, Wall Street Journal, TIME, Wired, Atlantic Monthly, The Harvard Business Review and Forbes.